COPD Prognosis in Covid Patients

Sponsor

Sohag University (Other)

Overall Status

Completed

CT.gov ID

NCT05274490

Collaborator

(none)

100

Enrollment

Location

Actual Duration (Months)

14.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.

Condition or Disease	Intervention/Treatment	Phase
Respiratory Failure	Procedure: intubation and mechanical ventilation

Study Design

Study Type:

Observational [Patient Registry]

Actual Enrollment :

100 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection

Actual Study Start Date :

Jun 1, 2021

Actual Primary Completion Date :

Dec 1, 2021

Actual Study Completion Date :

Jan 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
copd patients with covid infection	Procedure: intubation and mechanical ventilation patients who were in need were intubated and mechanically ventilated
non-copd patients with covid infection	Procedure: intubation and mechanical ventilation patients who were in need were intubated and mechanically ventilated

Arm

Intervention/Treatment

copd patients with covid infection

Procedure: intubation and mechanical ventilation

patients who were in need were intubated and mechanically ventilated

non-copd patients with covid infection

Procedure: intubation and mechanical ventilation

patients who were in need were intubated and mechanically ventilated

Outcome Measures

Primary Outcome Measures

SOFA score measurement in both groups [2 weeks]
monitoring of SOFA items along two weeks

Secondary Outcome Measures

prognosis of the disease [2 weeks]
hospital stay, nedd for mechanical ventilation

Eligibility Criteria

Criteria

Ages Eligible for Study:

20 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Age: more than 20 years old.
Both Males and females will be included.
COPD patients.
Recent confirmed the diagnosis with SARS-COV-2.

Exclusion Criteria:

Pregnancy.
Malignancy.
Immunodeficiency disease

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Faculty of Medicine, Sohag University	Sohag		Egypt

Sponsors and Collaborators

Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Islam Mokhtar Ahmed, lecturer of anesthesia and intensive care, Sohag University

ClinicalTrials.gov Identifier:

NCT05274490

Other Study ID Numbers:

soh-Med-22-1-26

First Posted:

Mar 10, 2022

Last Update Posted:

Mar 10, 2022

Last Verified:

Mar 1, 2022

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Islam Mokhtar Ahmed, lecturer of anesthesia and intensive care, Sohag University

copd, prognosis, covid

Additional relevant MeSH terms:

Respiratory Insufficiency

Study Results

No Results Posted as of Mar 10, 2022